These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26970083)

  • 1. A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B-cells.
    Medves S; Auchter M; Chambeau L; Gazzo S; Poncet D; Grangier B; Verney A; Moussay E; Ammerlaan W; Brisou G; Morjani H; Géli V; Palissot V; Berchem G; Salles G; Wenner T
    Br J Haematol; 2016 Jul; 174(1):57-70. PubMed ID: 26970083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomeric Recombination Induced by DNA Damage Results in Telomere Extension and Length Heterogeneity.
    Liu H; Xie Y; Zhang Z; Mao P; Liu J; Ma W; Zhao Y
    Neoplasia; 2018 Sep; 20(9):905-916. PubMed ID: 30118998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP1 modulates telomere sister chromatid exchange and telomere length homeostasis by regulating telomere localization of SLX4 in U2OS cells.
    Sadhukhan R; Ghosh U
    Life Sci; 2021 Jul; 277():119556. PubMed ID: 33945829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus.
    Kamranvar SA; Chen X; Masucci MG
    Oncogene; 2013 Dec; 32(49):5522-30. PubMed ID: 23708666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.
    Poncet D; Belleville A; t'kint de Roodenbeke C; Roborel de Climens A; Ben Simon E; Merle-Beral H; Callet-Bauchu E; Salles G; Sabatier L; Delic J; Gilson E
    Blood; 2008 Feb; 111(4):2388-91. PubMed ID: 18077792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres.
    Wang Y; Erdmann N; Giannone RJ; Wu J; Gomez M; Liu Y
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10256-60. PubMed ID: 16000404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells.
    Bailey SM; Brenneman MA; Goodwin EH
    Nucleic Acids Res; 2004; 32(12):3743-51. PubMed ID: 15258249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment.
    Jung AR; Yoo JE; Shim YH; Choi YN; Jeung HC; Chung HC; Rha SY; Oh BK
    Anticancer Res; 2013 Mar; 33(3):821-9. PubMed ID: 23482750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere recombination requires the MUS81 endonuclease.
    Zeng S; Xiang T; Pandita TK; Gonzalez-Suarez I; Gonzalo S; Harris CC; Yang Q
    Nat Cell Biol; 2009 May; 11(5):616-23. PubMed ID: 19363487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
    Bechter OE; Eisterer W; Pall G; Hilbe W; Kühr T; Thaler J
    Cancer Res; 1998 Nov; 58(21):4918-22. PubMed ID: 9810000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange.
    Londoño-Vallejo JA; Der-Sarkissian H; Cazes L; Bacchetti S; Reddel RR
    Cancer Res; 2004 Apr; 64(7):2324-7. PubMed ID: 15059879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells.
    Tilman G; Loriot A; Van Beneden A; Arnoult N; Londoño-Vallejo JA; De Smet C; Decottignies A
    Oncogene; 2009 Apr; 28(14):1682-93. PubMed ID: 19252523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.
    Hoxha M; Fabris S; Agnelli L; Bollati V; Cutrona G; Matis S; Recchia AG; Gentile M; Cortelezzi A; Morabito F; Bertazzi PA; Ferrarini M; Neri A
    Genes Chromosomes Cancer; 2014 Jul; 53(7):612-21. PubMed ID: 24706380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient activation of the ALT pathway in human primary fibroblasts exposed to high-LET radiation.
    Berardinelli F; Antoccia A; Cherubini R; De Nadal V; Gerardi S; Cirrone GA; Tanzarella C; Sgura A
    Radiat Res; 2010 Nov; 174(5):539-49. PubMed ID: 20726710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Telomere length and telomerase expression activity in mononuclear cells of patients with chronic lymphocytic leukemia].
    Ma L; Wang J; Jiang B; Liu YR; Zhang B; Chang NB; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1409-12. PubMed ID: 20030916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative lengthening of telomeres is induced by telomerase inhibitors in Barrett's esophageal cells.
    Qin X; Qi B; Zhao B
    Oncol Rep; 2013 Apr; 29(4):1399-404. PubMed ID: 23338150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere exchange and asymmetric segregation of chromosomes can account for the unlimited proliferative potential of ALT cell populations.
    Blagoev KB; Goodwin EH
    DNA Repair (Amst); 2008 Feb; 7(2):199-204. PubMed ID: 18006387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia.
    Samassekou O; Malina A; Hébert J; Yan J
    J Hematol Oncol; 2013 Apr; 6():26. PubMed ID: 23547895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications.
    Hultdin M; Rosenquist R; Thunberg U; Tobin G; Norrback KF; Johnson A; Sundström C; Roos G
    Br J Cancer; 2003 Feb; 88(4):593-8. PubMed ID: 12592375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.